ABVC BioPharma, Inc. (ABVC)
0.8905
+0.06
(+7.29%)
USD |
NASDAQ |
Aug 31, 16:00
0.8905
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Cash from Operations (TTM) : -2.691M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.691M |
| March 31, 2026 | -3.341M |
| December 31, 2025 | -2.986M |
| September 30, 2025 | -2.646M |
| June 30, 2025 | -1.621M |
| March 31, 2025 | -0.9385M |
| December 31, 2024 | -1.354M |
| September 30, 2024 | -1.693M |
| June 30, 2024 | -2.614M |
| March 31, 2024 | -3.270M |
| December 31, 2023 | -4.187M |
| September 30, 2023 | -4.243M |
| June 30, 2023 | -3.874M |
| March 31, 2023 | -6.460M |
| December 31, 2022 | -7.638M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -9.946M |
| June 30, 2021 | -6.760M |
| March 31, 2021 | -6.757M |
| December 31, 2020 | -6.042M |
| September 30, 2020 | -3.50M |
| June 30, 2020 | -4.271M |
| Date | Value |
|---|---|
| March 31, 2020 | -3.396M |
| December 31, 2019 | -3.308M |
| September 30, 2019 | -2.711M |
| June 30, 2019 | -2.483M |
| March 31, 2019 | -2.267M |
| December 31, 2018 | -2.255M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| December 31, 2016 | -2.825M |
| September 30, 2016 | -3.475M |
| June 30, 2016 | -3.266M |
| March 31, 2016 | -0.4296M |
| December 31, 2015 | -0.875M |
| September 30, 2015 | -0.0007M |
| June 30, 2015 | -0.0032M |
| March 31, 2015 | -0.0056M |
| December 31, 2014 | -0.0056M |
| September 30, 2014 | -0.0056M |
| June 30, 2014 | -0.0001M |
| March 31, 2014 | -0.0002M |
| December 31, 2013 | -0.0014M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Anika Therapeutics, Inc. | 5.977M |
| Perspective Therapeutics, Inc. | -93.07M |
| MiMedx Group, Inc. | 46.13M |
| Abbott Laboratories | 9.905B |
| AngioDynamics, Inc. | 3.089M |